相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。The Role of Receptor for Advanced Glycation End Products (RAGE) in the Proliferation of Hepatocellular Carcinoma
Al-Madhagi Yaser et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2012)
Near-infrared imaging of breast cancer using optical contrast agents
Alexander Poellinger
JOURNAL OF BIOPHOTONICS (2012)
Receptor for advanced glycation end products (RAGE) partially mediates HMGB1-ERKs activation in clear cell renal cell carcinoma
Liguo Lin et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2012)
Nuclear NF-κB/p65 expression and response to neoadjuvant chemotherapy in breast cancer
Robin L. Jones et al.
JOURNAL OF CLINICAL PATHOLOGY (2011)
Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists
Sunil Badve et al.
MODERN PATHOLOGY (2011)
Chemopreventive Activity of Vitamin E in Breast Cancer: A Focus on γ- and δ-Tocopherol
Amanda K. Smolarek et al.
NUTRIENTS (2011)
High-mobility group box 1 and cancer
Daolin Tang et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2010)
Triple-Negative Breast Cancer
William D. Foulkes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Subtyping of Breast Cancer by Immunohistochemistry to Investigate a Relationship between Subtype and Short and Long Term Survival: A Collaborative Analysis of Data for 10,159 Cases from 12 Studies
Fiona M. Blows et al.
PLOS MEDICINE (2010)
Most Basal-like Breast Carcinomas Demonstrate the Same Rb-/p16+Immunophenotype as the HPV-related Poorly Differentiated Squamous Cell Carcinomas Which They Resemble Morphologically
Andrea Proctor Subhawong et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2009)
Multiple levels of regulation determine the role of the receptor for AGE (RAGE) as common soil in inflammation, immune responses and diabetes mellitus and its complications
A. Bierhaus et al.
DIABETOLOGIA (2009)
Regulated Proteolysis of RAGE and A beta PP as Possible Link Between Type 2 Diabetes Mellitus and Alzheimer's Disease
Elzbieta Kojro et al.
JOURNAL OF ALZHEIMERS DISEASE (2009)
Receptor for AGE (RAGE) and its ligands-cast into leading roles in diabetes and the inflammatory response
Shi Fang Yan et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2009)
Novel anticancer targets: revisiting ERBB2 and discovering ERBB3
Jose Baselga et al.
NATURE REVIEWS CANCER (2009)
Molecular subtypes in breast cancer evaluation and management: Divide and conquer
Jeffrey Peppercorn et al.
CANCER INVESTIGATION (2008)
Interaction of the RAGE Cytoplasmic Domain with Diaphanous-1 Is Required for Ligand-stimulated Cellular Migration through Activation of Rac1 and Cdc42
Barry I. Hudson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer
Cornelia Liedtke et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
A novel function of the receptor for advanced glycation end-products (RAGE) in association with tumorigenesis and tumor differentiation of HCC
Kiyokazu Hiwatashi et al.
ANNALS OF SURGICAL ONCOLOGY (2008)
Triple negative breast cancer: molecular profiling and prognostic impact in adjuvant anthracycline-treated patients
David S. P. Tan et al.
BREAST CANCER RESEARCH AND TREATMENT (2008)
Triple negative tumours: a critical review
J. S. Reis-Filho et al.
HISTOPATHOLOGY (2008)
RAGE and RAGE ligands in cancer
Craig D. Logsdon et al.
CURRENT MOLECULAR MEDICINE (2007)
Integrating cell-signalling pathways with NF-kappa B and IKK function
Neil D. Perkins
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
Inflammation and breast cancer - Balancing immune response: crosstalk between adaptive and innate immune cells during breast cancer progression
David G. DeNardo et al.
BREAST CANCER RESEARCH (2007)
Arguing for the motion: Yes, RAGE is a receptor for advanced glycation endproducts
Ravichandran Ramasamy et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2007)
Introduction to NF-κB:: players, pathways, perspectives
T. D. Gilmore
ONCOGENE (2006)
Concordance among gene-expression-based predictors for breast cancer
Cheng Fan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Promotion of cell adherence and spreading: a novel function of RAGE, the highly selective differentiation marker of human alveolar epithelial type I cells
N Demling et al.
CELL AND TISSUE RESEARCH (2006)
Receptor for advanced glycation end products (RAGE) and its ligand, amphoterin are overexpressed and associated with prostate cancer development
H Ishiguro et al.
PROSTATE (2005)
Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma
TO Nielsen et al.
CLINICAL CANCER RESEARCH (2004)
Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response
B Liliensiek et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Expression of luminal and basal cytokeratins in human breast carcinoma
DMA El-Rehim et al.
JOURNAL OF PATHOLOGY (2004)
Oncogenes and tumor suppressor genes in breast cancer: Potential diagnostic and therapeutic applications
C Osborne et al.
ONCOLOGIST (2004)
In human hepatocellular carcinoma in cirrhosis, proliferating cell nuclear antigen (PCNA) is involved in cell proliferation and cooperates with P21 in DNA repair
L Gramantieri et al.
JOURNAL OF HEPATOLOGY (2003)
Expression analysis of S100 proteins and RAGE in human tumors using tissue microarrays
HL Hsieh et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
Differential effects between amphoterin and advanced glycation end products on colon cancer cells
H Kuniyasu et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
HMGB1 inhibits cell death in yeast and mammalian cells and is abundantly expressed in human breast carcinoma
ML Brezniceanu et al.
FASEB JOURNAL (2003)
The genetics and genomics of cancer
A Balmain et al.
NATURE GENETICS (2003)
Molecular alterations in sporadic breast cancer
F Lerebours et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2002)
Expression of receptors for advanced glycation end-products (RAGE) is closely associated with the invasive and metastatic activity of gastric cancer
H Kuniyasu et al.
JOURNAL OF PATHOLOGY (2002)
N-glycans on the receptor for advanced glycation end products influence amphoterin binding and neurite outgrowth
G Srikrishna et al.
JOURNAL OF NEUROCHEMISTRY (2002)
The human HMGB1 promoter is modulated by a silencer and an enhancer-containing intron
HK Lum et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION (2001)
Requirement for p38 and p44/p42 mitogen-activated protein kinases in RAGE-mediated nuclear factor-κB transcriptional activation and cytokine secretion
CH Yeh et al.
DIABETES (2001)
Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases
A Taguchi et al.
NATURE (2000)